Taysha
driven by a relentless focus on discovering developing and commercializing novel based gene therapies for devastating disorders of the central nervous system | Taysha
Company
Deck Type
IPO
Deck date
September 2020
Slide
4 of 66
Search Thousands of Presentations by World Leading Companies